Healthscope – Takeover Offer

Healthscope has been one of our “high conviction” buy ideas.

Brookfield Capital Partners are finalising due diligence and we expect to see their offer formalised in the coming weeks.

You’re not a member!  Trial today

The price gap is now closing, (all cash offer $2.44), as HSO trades at $2.40 today.

Ready to elevate your investing?

Join Investor Signals today and start your journey to better, more disciplined returns.